Dear Dr. Renukaprasad A R,
A major global health issue, urinary tract infections (UTIs) are frequently observed in outpatient clinics, emergency room visits, as well as in hospitalized patients. Its estimated annual incidence is close to 150 million new cases. Given its high prevalence, there is a need to implement proper antibiotic stewardship.
Insulin resistance, which causes hyperglycemia and a progressive decline in the beta-cells' capacity to release insulin, is primarily responsible for the pathophysiology of T2DM. The condition has both macrovascular and microvascular consequences. However, an antidiabetic drug class, SGLT-2 inhibitors, has helped manage diabetes and its complications better.
To gain detailed insights into "
UTI Management | SGLT-2 Inhibitors for the Diabetic Heart," join the renowned Infectious disease consultant,
Dr. Surabhi Madan, and eminent Diabetologist,
Dr. Sunder Mudaliar, in our exclusive session, organized in association with CIMS,
TODAY,
6:00 PM IST onwards.
.jpg "banner")
No comments:
Post a Comment